2016
DOI: 10.1152/ajplung.00370.2016
|View full text |Cite
|
Sign up to set email alerts
|

Emerging concepts in smooth muscle contributions to airway structure and function: implications for health and disease

Abstract: Airway structure and function are key aspects of normal lung development, growth, and aging, as well as of lung responses to the environment and the pathophysiology of important diseases such as asthma, chronic obstructive pulmonary disease, and fibrosis. In this regard, the contributions of airway smooth muscle (ASM) are both functional, in the context of airway contractility and relaxation, as well as synthetic, involving production and modulation of extracellular components, modulation of the local immune e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
118
0
3

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 114 publications
(122 citation statements)
references
References 607 publications
(641 reference statements)
1
118
0
3
Order By: Relevance
“…We have previously shown that human fASM expresses IP3R (Hartman et al, 2012) and results from our current study with U73122 (PLC inhibitor), PLCβ siRNA, and XeC (IP 3 R blocker) underline the link between CaSR and the PLC-IP 3 pathway in developing ASM. The expression and role of TRPC channels in adult ASM has also been previously demonstrated (Prakash, 2016;Wang & Zheng, 2011) and we have previously reported expression of TRPC channels (Hartman et al, 2012) Our data demonstrate that CaSR promotes proliferation of fASM cells, a novel finding. Here, the PLC pathway appears to be at least one mechanism by which CaSR functions.…”
Section: Casr Functionality Is Present In Human Fasmsupporting
confidence: 79%
See 1 more Smart Citation
“…We have previously shown that human fASM expresses IP3R (Hartman et al, 2012) and results from our current study with U73122 (PLC inhibitor), PLCβ siRNA, and XeC (IP 3 R blocker) underline the link between CaSR and the PLC-IP 3 pathway in developing ASM. The expression and role of TRPC channels in adult ASM has also been previously demonstrated (Prakash, 2016;Wang & Zheng, 2011) and we have previously reported expression of TRPC channels (Hartman et al, 2012) Our data demonstrate that CaSR promotes proliferation of fASM cells, a novel finding. Here, the PLC pathway appears to be at least one mechanism by which CaSR functions.…”
Section: Casr Functionality Is Present In Human Fasmsupporting
confidence: 79%
“…[Ca 2+ ] i regulation is a recognized aspect of ASM contractility (Mahn et al, 2010;Prakash, 2016;Sakai et al, 2017) but compared with adult ASM, regulatory aspects in developing ASM are less understood, partly due to lack of age-appropriate cell/tissue models, particularly in humans.…”
Section: Casr Functionality Is Present In Human Fasmmentioning
confidence: 99%
“…A second limitation of our model is the use of whole lung tissue to study gene expression differences. As conducted, our approach cannot identify changes in specific cell types, such as resident or recruited immune cells, as well as in lung compartments such as the endothelium or vascular, which have been identified as important contributors of sexual dimorphism in lung diseases such as asthma (Prakash ). In fact, some of the differential gene expression networks identified display associations with connective tissue disorders, cell‐to‐cell signaling, and hematologic systems.…”
Section: Discussionmentioning
confidence: 99%
“…Expression of [Ca 2+ ] i regulatory proteins, such as those for SR Ca 2+ release and Ca 2+ influx, are known to be upregulated in ASM of patients with asthma or with inflammatory mediators (52). In the present study, using LCM, we examined mRNA expression of several [Ca 2+ ] i regulatory proteins in the ASM layer.…”
Section: A B Bmentioning
confidence: 99%
“…[Ca 2+ ] i regulation is central to modulation of ASM contraction/relaxation and to ASM hypercontractility observed in patients with asthma (52). In addition to several inflammatory cytokines that are known to enhance baseline levels and [Ca 2+ ] i responses to bronchoconstrictor agonists, BDNF has emerged as a key regulator of contractility in human ASM (30,35).…”
Section: A B Bmentioning
confidence: 99%